Diffusion-weighted imaging for prostate cancer localization: Comparison of apparent diffusion coefficient values in cancerous, non-cancerous tissues and Gleason score of the radical prostatectomy specimens

Japanese Journal of Urology

Volumn 104, Issue 3, 2013, Pages 489-495

  Kobayashi, Hirohito ^a   Kitamura, Kosuke ^a   Mizukami, Sainosuke ^a   Hanazawa, Kisaburo ^a   Sakamoto, Yoshiro ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Apparent diffusion coefficient value; Diffusion weighted imaging; Prostate cancer

Indexed keywords

EID: 84879247255     PISSN: 00215287     EISSN: None     Source Type: Journal    
DOI: 10.5980/jpnjurol.104.489     Document Type: Article

References (16)

1. Sobin LH and Wittekind Ch: TNM Classification of Malignant Tumors, 5th ed, Wiley-Liss., 1997.
2. Fiebach JB, Schellinger PD, Jansen O, Meyer M, Wilde P, Bender J, Schramm P, Jüttler E, Oehler J, Hartmann M, Hähnel S, Knauth W, Hacke M and Sartor HK: CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke, 33, 2206-2210, 2002.
3. Katahira K, Takahara T, Kwee TC, Oda S, Suzuki Y, Morishita S, Kitani K, Hamada Y, Kitaoka M and Yamashita Y: Ultra-high-b-value diffusion-weigh ted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation. Eur Radiol, 21, 188-196, 2011.
4. Haider MA, Van Der Kwast TH, Tanguay J, Evans AJ, Hashmi AT, Lockwood G and Trachtenberg J: Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. Am J Roentgenol, 189, 323-328, 2007.
5. Morgan VA, Kyriazi S, Ashley SE and De Souza NM: Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection. Acta Radiol, 6, 695-703, 2007.
6. Shimofusa R, Fujimoto H, Akamata H, Motoori K, Yamamoto S, Ueda T and Ito H: Diffusion-weighted imaging of prostate cancer. J Comput Assist Tomogr, 29, 149-153, 2005.
7. Yoshizako T, Wada A, Uchida K, Hara S, Igawa M, Kitagaki H and Maier SE: Apparent diffusion coefficient of line scan diffusion image in normal prostate and prostate cancer-comparison with single-shot echo planner image. Magn Reson Imaging, 29, 106-110, 2011.
8. 2. Am J Roentgenol, 194, W33-37, 2010.
9. Kitajima K, Kaji Y, Kuroda K and Sugimura K: High b-value diffusion-weighted imaging in normal and malignant peripheral zone tissue of the prostate: effect of signal-to-noise ratio. Magn Reson Med Sci, 7, 93-99, 2008.
10. Kim JH, Kim JK, Park BW, Kim N and Cho KS: Apparent diffusion coefficient: prostate cancer versus noncancerous tissue according to anatomical region. J Magn Reson Imaging, 28, 1173-1179, 2008.
11. Tamada T, Sone T, Jo Y, Toshimitsu S, Yamashita T, Yamamoto A, Tanimoto D and Ito K: Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade. J Magn Reson Imaging, 28, 720-726, 2008.
12. Tanimoto A, Nakashima J, Kohno H, Shinmoto H and Kuribayashi S: Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging, 25, 146-52, 2007.
13. Pickles MD, Gibbs P, Sreenivas M and Turnbull LW: Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0T. J Magn Reson Imaging, 23. 130-134, 2006.
14. Sato C, Naganawa S, Nakamura T, Kumada H, Miura S, Takizawa O and Ishigaki T: Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging, 21, 258-262, 2005.
15. Issa B: In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging, 16, 196-200, 2002.
16. Zelhof B, Pickles M, Liney G, Gibbs P, Rodrigues G, Kraus S and Turnbull L: Correlation of diffusionweighted magnetic resonance data with cellularity in prostate cancer. BJU Int, 103, 883-888, 2008.